Search for content, post, videos

Biotage’s acquisition of Horizon Technology is closed


Biotage announces the closing of the acquisition of all outstanding shares in the privately held company Horizon Technology, based in New Hampshire, US, in accordance with contract and public announcement of December 6th, 2017.

The purchase price adjusted for actual net cash at the closing date is approximately USD 17.9 million, corresponding to approx. SEK 143.4 million, based on an enterprise value of approximately USD 16.4 million and cash of approximately USD 1.5 million.